发明名称 HYBRID MOLECULES CONTAINING AMIDATED POLYPEPTIDE BINDING LIGANDS
摘要 Disclosed are hybrid molecules containing a first part, a second part and third part connected by covalent bonds. The first part contains a chemical entity to be introduced into an animal cell. The second part contains a polypeptide effective to translocate the chemical entity across the cytoplasmic membrane and into the cytoplasm of the animal cell. The third part contains a C-terminal amidated polypeptide ligand effective to cause the hybrid molecule to bind to the animal cell. The amidated hybrid molecules exhibit greater biological activity than non-amidated counterparts. Preferred hybrid molecules are fusion toxins which contain an amidated neuropeptide, e.g., substance P or gastrin releasing peptide. Methods of preparing the hybrid molecules, which in preferred embodiments are prepared enzymatically by peptidlglycine- alpha -amidating monooxygenase, are also disclosed. Further disclosed are methods of using the hybrid molecules for medical purposes, such as in the fields of diagnostics and therapeutics.
申请公布号 WO9713410(A1) 申请公布日期 1997.04.17
申请号 WO1996US16237 申请日期 1996.10.11
申请人 BOSTON MEDICAL CENTER CORPORATION;LEEMAN, SUSAN, E.;MURPHY, JOHN, R.;VANDERSPEK, JOHANNA, C.;FISHER, CAROLINE, E. 发明人 LEEMAN, SUSAN, E.;MURPHY, JOHN, R.;VANDERSPEK, JOHANNA, C.;FISHER, CAROLINE, E.
分类号 A61K38/00;A61K47/48;C07K7/22;C07K14/34;C07K14/575;C07K19/00;G01N33/48;(IPC1-7):A01N37/18;A01N43/50;C07H21/04;C12P21/04;C12P21/06 主分类号 A61K38/00
代理机构 代理人
主权项
地址